Endoscope reprocessing is a multi-step process that includes thorough cleaning, disinfection, and sterilization of endoscopes and associated attachments. The endoscope reprocessing tag applies to endoscopes undergoing the endoscope reprocessing procedure. The significant risk of infections resulting from poor endoscopic instrument sterilization drives the demand for reprocessing equipment.
Endoscopy is one of the most common medical procedures undertaken. It is used for the early identification, diagnosis, and treatment of gastrointestinal disorders. The rise in gastro-related problems increases the number of endoscopic procedures performed and, eventually, the demand for reprocessing endoscopes to reduce the risk of infection for patients and physicians. The rate of increase in endoscopic operations is proportional to the prevalence of malignancies of the gastrointestinal tract. Since more and more people are experiencing stomach difficulties, endoscopy is required more frequently compared to the past. This increase in endoscope usage increases the likelihood of biofilm growth on endoscopes.
According to the CDC analysis, AERs offer advantages over manual endoscope reprocessing procedures because they automate many reprocessing steps and minimize worker exposure to high-level disinfectants. Cleaning endoscopes was complex because it was only recently possible to clean their lumens. Several manufacturers stress the automation of their disinfection procedures to define their product developments and innovation strategies. Thus, technical advancements in endoscope reprocessing procedures generate the potential for market expansion.
North America is the most significant shareholder in the global endoscope reprocessing market and is anticipated to grow at a CAGR of 8.01% during the forecast period. In North America, the demand for disinfection systems is driven primarily by the increasing prevalence of chronic diseases, HAIs, stringent regulations, and favorable government initiatives related to disinfection and sterilization. In the following years, advancements in healthcare infrastructure in the United States and Canada are anticipated to increase the demand for disinfectants and detergents in healthcare settings. The convenience and ease of use of these goods have led to a rise in orders for them in various end-user application categories.
In addition, the demand for automated endoscope reprocessors that permit high-level disinfection of endoscopes is expected to increase as the number of endoscopic surgical procedures fluctuates. Guidelines from the government that encourage the reprocessing of medical devices and an increase in the number of product approvals for automated endoscope reprocessors are also driving up demand in the region for endoscope reprocessors and accessories.
Europe is expected to grow at a CAGR of 8.30% over the forecast period. The market in the region is expanding due to the aging population with chronic diseases and the rise of HAIs and hospitalizations. Increased healthcare infrastructure, technical advancements in the medical industry, and the development of smart devices for disinfection systems all contribute to the regional market's growth. The COVID-19 outbreak demanded the disinfection of healthcare facilities and hand hygiene for physicians and patients, contributing to the regional market expansion. In addition, digestive tract cancer accounts for 28% of all cancer-related fatalities in the region. The number of patients requiring endoscopic procedures is considerable, driving the regional market's expansion.